PET/CT: Nasopharyngeal Cancers

Chenyi Xie; Varut Vardhanabhuti

doi:10.1016/j.cpet.2021.12.006

PET/CT: Nasopharyngeal Cancers

PET Clin. 2022 Apr;17(2):285-296. doi: 10.1016/j.cpet.2021.12.006. Epub 2022 Mar 4.

Authors

Chenyi Xie¹, Varut Vardhanabhuti²

Affiliations

¹ Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, K406, Block K, Queen Mary Hospital, Pokfulam Road, Hong Kong SAR, China.
² Department of Diagnostic Radiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, K406, Block K, Queen Mary Hospital, Pokfulam Road, Hong Kong SAR, China. Electronic address: varv@hku.hk.

PMID: 35256301
DOI: 10.1016/j.cpet.2021.12.006

Abstract

PET/CT scan has been used as a tool for the diagnosis and management of nasopharyngeal carcinoma (NPC). It has been proven to be highly valuable for the imaging and management of patients with NPC with strengths in N and M staging as well as treatment planning and is recommended to be incorporated into the standard clinical assessment. Novel quantitative techniques such as the use of radiomics may provide valuable prognostic information.

Keywords: Diagnostic imaging; Nasopharyngeal cancers; PET; Staging.

Publication types

Review

MeSH terms

Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Nasopharyngeal Carcinoma / diagnostic imaging
Nasopharyngeal Carcinoma / pathology
Nasopharyngeal Neoplasms* / diagnostic imaging
Nasopharyngeal Neoplasms* / pathology
Nasopharyngeal Neoplasms* / therapy
Neoplasm Staging
Positron Emission Tomography Computed Tomography* / methods

Substances

Fluorodeoxyglucose F18